Pliant Therapeutics Inc (NASDAQ:PLRX) currently has a daily average trading volume of 2.58M but it saw 1471403 shares traded in last market. With a market cap of 90.02M USD, the company’s current market price of $1.47 came falling about -1.34 while comparing to the previous closing price of $1.49. In past 52 weeks, the stock remained buoying in the range of price level as high as $16.52 and as low as $1.26. In the recent trading on the day, stock has struck highest price mark of $1.42 while lowest mark touched by it was $1.52.
Taking a look at 20-day trading activity of Pliant Therapeutics Inc (PLRX) gives us an average price of $1.7237, while its current price level is -91.10% below from 52-week high level whereas it is 16.67% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $5.4044 while that of 200 days or SMA-200 reads an average of $11.0091. A closer look into the stock’s movement over the week reveals that its volatility is standing at 8.21% during that period while stretching the period over a month that increases to 16.96%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 26.17 which implies that the stock is in oversold territory.
Over the week, PLRX’s stock price is moving -9.26% down while it is -53.63% when we observe its performance for the past one month. Year-to-date it is -88.84% down and over the past year, the stock is showing a downside performance of -89.97%.
The company is expected to be releasing its next quarterly report on 2025-Mar-02, for which analysts forecasted an EPS of -0.75 while estimate for next year EPS is -2.29.
Currently, Pliant Therapeutics Inc’s total number of outstanding shares is 60.86M with 3.27% of that held by the insiders while 117.06% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -57.82% and return on equity (ROE) at -54.09%. Stock’s beta reads 1.36. Stock has a price to book (P/B) ratio of 0.29. Its return on asset (ROA) is -46.27% on average.
